[NLSP] YoY Annual Result on 31-Dec-2020 [#FY]

Stock
[NLSP] NLS Pharmaceutics AG
Announcement Date
14-May-2021
Financial Year
2020
Quarter
31-Dec-2020 [#FY]
Profit Trend
YoY- 47.48%
Quarter Report
NLSP's Result
NLSP's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -12,172 -16,496 -11,946 -2,861 -5,447 -5,147 -6,657 10.57%
Tax 0 0 -227 -2 -4 1,698 -6 -
NP -12,172 -16,496 -11,946 -2,861 -5,447 -5,147 -6,657 10.57%
Tax Rate - - - - - - - -
Total Cost 12,172 16,496 11,946 2,861 5,447 5,147 6,657 10.57%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.32 -0.84 -0.81 -0.59 -0.49 -0.44 -0.57 -9.16%
EPS Diluted -0.32 -0.84 -0.81 -0.59 -0.49 -0.44 -0.57 -9.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.